Brooks Laboratories Ltd. Live Share Price Today, Share Analysis and Chart

Name: Brooks Laboratories Ltd.: Is Infosys Ltd. worth buying?
Item: Brooks Laboratories Ltd.
Rating: 1.927791625
Author: Trendlyne DVM scores

Expensive Performer

about

Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.

150.96 2.96 (2.00%)

66.95% Gain from 52W Low

19,872

NSE+BSE Volume

NSE 30 Jul, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

45.0 / 100

Expensive Valuation

9.8 / 100

Technically Neutral

54.4 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

No estimates available

Brooks Laboratories Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Brooks Laboratories Ltd. worth buying?

23 Votes:

Buy 82.61%

Sell 13.04%

Hold 4.35%

Brooks Laboratories Ltd. Live Share Price Today, Share Analysis and Chart

Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.

66.95% Gain from 52W Low

SWOT Analysis

Brooks Laboratories Live Price Chart